AVE 16.7% 0.3¢ avecho biotechnology limited

IMO funding is dependant on the success of the aod/tpm focus...

  1. 4,155 Posts.
    lightbulb Created with Sketch. 67
    IMO funding is dependant on the success of the aod/tpm focus group . A good result is a license to print money . The results are expected mid March MMMMMMM . Large investors are trapped by the lack of liquidity & believe this is their only chance to bail or consider their options . The insto's will be saying " and this will be the last time "
    Ironic that a coy with such pharmaceutical potential may be saved by the vanity of women .
    If it was my clients money I'd be seeking changes in the executive as part of the deal confirmed by the Elixxia MK2 absurdity .
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
-0.001(16.7%)
Mkt cap ! $7.923M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $194 65.5K

Buyers (Bids)

No. Vol. Price($)
51 89002619 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 59773414 19
View Market Depth
Last trade - 12.52pm 20/08/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.